4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-23-011547
Chief Financial Officer bought 5,000 shares at $3.73 ($18,632)
From the SEC's structured data for this filing
Trades in this filing
Celano Michael · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-17 | Purchase : show line 1 in the form | +5,000 | $3.73 | $18,632 | 112,746 | D |
| Open-market purchases · 5,000 sh · avg $3.73 · $18,632 | ||||||
Loading xslF345X04/form4.xml…